World Journal of Gastroenterology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 30, Issue 25

This Article

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (4365)

All Articles published online

The chart showing PDF series, HTML series.

Item

Count

PDF

167

HTML

2036

Sum=2203

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

297

Download

584

Sum=881

Publishing Process of This Article

Item

Count

Browse

321

Download

726

Sum=1047

Jul 7, 2024 (publication date) through May 1, 2026

Times Cited of This Article

Times Cited (6)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Cited by in CrossRef

For:	Lowell JA, Farber MJ, Sultan K. Back to the drawing board: Overview of the next generation of combination therapy for inflammatory bowel disease. World J Gastroenterol 2024; 30(25): 3182-3184 [PMID: 39006384 DOI: 10.3748/wjg.v30.i25.3182]
URL:	https://www.wjgnet.com/1007-9327/full/v30/i25/3182.htm

Number	Citing Articles
1	Wen-Ting Xie, Hui Yang, Lan Bai, Feng-Fei Wu. New perspectives and prospects for the next generation of combination therapy in inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(5): 99462 doi: 10.3748/wjg.v31.i5.99462 Abstract(564) \| Core Tip(616) \| Full Article(HTML)(1959) \| Full Article with Cover (PDF)-583K(1814) \| Audio-1118K(22) \| Peer-Review Report-178K(114) \| Answering Reviewers-41K(95) \| Full Article (PDF)-364K(172) \| Full Article (XML)-68K(111) \| Times Cited (3) \| Total Visits (6819) \| Open
2	M. Iborra, B. Botella, M. D. Martín‐Arranz, D. Ceballos, C. Martínez‐Pascual, A. Garrido, P. Varela, M. Moreta, E. Brunet‐Mas, Y. González‐Lama, E. Rodríguez‐González, M. Vicuña, J. P. Gisbert, I. Ordás, F. Argüelles‐Arias, J. Tosca‐Cuquerella, R. Vicente‐Lidón, M. Sierra‐Ausín, I. Rodríguez‐Lago, D. Martín‐Rodríguez, J. M. Paredes, B. Sicilia, I. García de la Filia, N. Jiménez, M. Barreiro‐de Acosta, E. Betoré, I. Ferrer‐Bradley, L. García‐Alles, J. M. Huguet, S. Castellet‐Farrús, M. J. García, A. Gutiérrez‐Casbas, Á. Ponferrada‐Díaz, L. Ramos, M. Calafat, I. Vera, C. Suárez‐Ferrer, E. Fernández‐Velado, S. Rodríguez‐Sánchez, A. Mínguez, A. Mancebo, J. Barrio, S. Lario, D. R. de La Cruz, Alejandro Hernández‐Camba, C. Rodríguez‐Gutiérrez, M. Chaparro, E. Ricart, L. Almenara‐Michelena, A. Balaguer, E. Domènech, P. Nos. Real‐World Effectiveness and Safety of Upadacitinib in Crohn's Disease: Insights From the Eneida Registry. United European Gastroenterology Journal 2026; 14(4) doi: 10.1002/ueg2.70223
3	Antonio M Caballero-Mateos, Guillermo Arturo Cañadas-de la Fuente. Game changer: How Janus kinase inhibitors are reshaping the landscape of ulcerative colitis management. World Journal of Gastroenterology 2024; 30(35): 3942-3953 doi: 10.3748/wjg.v30.i35.3942 Abstract(629) \| Core Tip(713) \| Full Article(HTML)(3866) \| Full Article with Cover (PDF)-2954K(186) \| Audio-1388K(25) \| Peer-Review Report-220K(126) \| Answering Reviewers-74K(112) \| Full Article (PDF)-2682K(306) \| Full Article (XML)-189K(133) \| Times Cited (11) \| Total Visits (8665) \| Open
4	Zi-Ning Zhang, Li-Xuan Sang. Dual-targeted treatment for inflammatory bowel disease: Whether fecal microbiota transplantation can be an important part of it. World Journal of Gastroenterology 2024; 30(36): 4025-4030 doi: 10.3748/wjg.v30.i36.4025 Abstract(646) \| Core Tip(559) \| Full Article(HTML)(2272) \| Full Article with Cover (PDF)-809K(124) \| Audio-772K(16) \| Peer-Review Report-244K(96) \| Answering Reviewers-132K(102) \| Full Article (PDF)-392K(145) \| Full Article (XML)-73K(101) \| Times Cited (2) \| Total Visits (6258) \| Open
5	Jia-Wang Yan, Mei Nie, Hang Zhang, Yan-Miao Liu, Fu-Shan Tang. Strengths, weaknesses, opportunities, and threats analysis of combination therapy for inflammatory bowel disease. World Journal of Gastroenterology 2025; 31(9): 100607 doi: 10.3748/wjg.v31.i9.100607 Abstract(614) \| Core Tip(526) \| Full Article(HTML)(2109) \| Full Article with Cover (PDF)-2846K(141) \| Audio-114K(13) \| Peer-Review Report-205K(90) \| Answering Reviewers-400K(101) \| Full Article (PDF)-1493K(157) \| Full Article (XML)-82K(113) \| Times Cited (1) \| Total Visits (5497) \| Open
6	Mei Kang, Daiyuan Tang, Wei Huang, Mingxia Zhou, Qiang Ma, Yining Lan, Deyi Chen, Ya Li, Bing Han. Emerging role of Itaconate in inflammatory bowel disease: From multitarget Immunometabolic mechanisms to therapeutic translation. International Immunopharmacology 2025; 166: 115632 doi: 10.1016/j.intimp.2025.115632